James T. Parsons, Director at DiaMedica Therapeutics Inc. (DMAC), bought 2,250 shares at $4.00 ($9K) on 2018-12-11, disclosed to the SEC on 2018-12-11.
Open-market purchase of $9k DMAC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |